Lower circulating levels of 1,25(OH)(2)D(3) are observed in patients with differentiated thyroid carcinoma. Further, while the alleles AA and FF of the ApaI (rs7975232) and FokI (rs10735810) VDR polymorphisms and the haplotype tABF confer to protection from follicular carcinoma, the haplotype Tabf appeared to be associated with an increased FTC risk. Since this is the first report associating VDR polymorphisms with thyroid carcinoma, these findings need to be confirmed in studies with larger numbers of patients.
A higher risk for DTC is conferred by haplotypes within the CYP24A1 gene, low circulating 25(OH)D(3) levels (deficiency), and a reduced conversion to 1,25(OH)(2)D(3). These results confirm and extend previous observations and also support a role of the vitamin D system in the pathogenesis of DTC. How deficient 25(OH)D(3) levels in combination with certain CYP24A1 haplotypes affect vitamin D activation is the subject of future studies.
Background: Common polymorphisms of the vitamin D receptor gene have been reported to affect the risk of breast, colon, prostate, and differentiated thyroid cancer (DTC), but polymorphisms within the genes of vitamin D metabolizing enzymes have not been studied in DTC. The aim of the present study was to investigate the genes for vitamin D enzymes in patients with DTC and healthy controls (HC) as well as the vitamin D (25hydroxyvitamin D 3 , and 1,25-hydroxyvitamin) status. Methods: German patients (n = 253) with DTC (papillary thyroid carcinoma [PTC] and follicular thyroid carcinoma [FTC]) and HC (n = 302) were genotyped for polymorphisms within the vitamin D metabolizing enzymes such as 25hydroxylase (CYP2R1[rs12794714, rs10741657]), 25-hydroxyvitamin D-1a-hydroxylase (CYP27B1[rs10877012, rs4646536]), and 25-hydroxyvitamin D 24-hydrolase (CYP24A1[rs927650, rs2248137, rs2296241]). Furthermore, the 25-hydroxyvitamin D 3 [25(OH)D 3 ] and 1,25-hydroxyvitamin [1,25(OH) 2 D 3 ] plasma levels were measured by a radioimmunoassay. Results: There was no difference in the genotypes; however, the CYP24A1 haplotype analysis showed that rs2248137C/rs2296241A (13.1% vs. 19.1%; corrected p [pc] = 0.04) was less frequent in the PTC, whereas the haplotypes rs2248137C/rs2296241G (56.0% vs. 41.9%; pc = 0.03), rs927650C/rs2296241G (22.5% vs. 8.4%; pc = 1.6 • 10-3), and rs927650C/rs2248137C/rs2296241G (21.1% vs. 7.3%; pc = 1.5 • 10-3) were more frequent in the FTC compared with HC. Furthermore, if patients and controls were grouped according to four 25(OH)D 3 categories (severely deficient, deficient, insufficient, and sufficient), then the patients with both DTC subtypes had significantly lower levels of circulating 1,25(OH) 2 D 3 , especially in the group with a deficient 25(OH)D 3 status compared with the controls. Although the polymorphisms showed no differences stratified for the four 25(OH)D 3 categories, the activation status by 1,25(OH) 2 D 3 differed significantly depending on the genotypes of the investigated CYP24A1 polymorphisms. Conclusions: A higher risk for DTC is conferred by haplotypes within the CYP24A1 gene, low circulating 25(OH)D 3 levels (deficiency), and a reduced conversion to 1,25(OH) 2 D 3. These results confirm and extend previous observations and also support a role of the vitamin D system in the pathogenesis of DTC. How deficient 25(OH)D 3 levels in combination with certain CYP24A1 haplotypes affect vitamin D activation is the subject of future studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.